A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3

Multidrug resistance (NIDR) is a major problem in the chemotherapeutic treatment of cancer. Overexpression of the multidrug resistance-associated protein 1 (MRP1), is associated with NIDR in certain tumors. A number of MRP1-specific MAbs, which facilitate both clinical and experimental investigations of this protein, are available. To add to this panel of existing antibodies, we have now generated an additional MRP1-specific monoclonal antibody (MAb), P2A8(6), which detects a unique heat stable epitope on the MRP1 molecule. Female Wistar rats were immunized via footpad injections with a combination of two short synthetic peptides corresponding to amino acids 235-246 (peptide A) and 246-260 (peptide B) of the MRP1 protein. Immune reactive B cells were then isolated from the popliteal lymph nodes for fusion with SP2/O-Ag14 myeloma cells. Resultant hybridoma supernatants were screened for MRP1-specific antibody production. Antibody P2A8(6) was characterized by Western blotting and immunocytochemistry on paired multidrug resistant (MRP1 overexpressing) and sensitive parental cell lines. The antibody detects a protein of 190 kDa in MRP1-expressing cell lines but not in MRP2- or MRP3-transfected cell lines. P2A8(6) stains drug-selected and MRP1-transfected cell lines homogeneously by immunocytochemistry and recognizes MRP1 by immunohistochemistry on formalin-fixed paraffin wax-embedded tissue sections. Peptide inhibition studies confirm that P2AS(6) reacts with peptide B (amino acids 246-260), therefore recognizing a different epitope from that of all currently available MRP1 MAbs. This new MAb, chosen for its specificity to the MRP1 protein, may be a useful addition to the currently available range of MRP1-specific MAbs.

Genome-wide Association Study Identifies SESTD1 as a Novel Risk Gene for Lithium Responsive Bipolar Disorder

Lithium is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies considerably across individuals. Patients who respond well to lithium treatment might represent a relatively homogeneous subtype of this genetically and phenotypically diverse disorder. Here, we performed genome-wide association studies (GWAS) to identify (i) specific genetic variations influencing lithium response and (ii) genetic variants associated with risk for lithium-responsive BD. Patients with BD and controls were recruited from Sweden and the United Kingdom. GWAS were performed on 2698 patients with subjectively defined (self-reported) lithium response and 1176 patients with objectively defined (clinically documented) lithium response. We next conducted GWAS comparing lithium responders with healthy controls (1639 subjective responders and 8899 controls; 323 objective responders and 6684 controls). Meta-analyses of Swedish and UK results revealed no significant associations with lithium response within the bipolar subjects. However, when comparing lithium-responsive patients with controls, two imputed markers attained genome-wide significant associations, among which one was validated in confirmatory genotyping (rs116323614, P=2.74 × 10-8). It is an intronic single-nucleotide polymorphism (SNP) on chromosome 2q31.2 in the gene SEC14 and spectrin domains 1 (SESTD1), which encodes a protein involved in regulation of phospholipids. Phospholipids have been strongly implicated as lithium treatment targets. Furthermore, we estimated the proportion of variance for lithium-responsive BD explained by common variants ('SNP heritability') as 0.25 and 0.29 using two definitions of lithium response. Our results revealed a genetic variant in SESTD1 associated with risk for lithium-responsive BD, suggesting that the understanding of BD etiology could be furthered by focusing on this subtype of BD.

Aspectos biológico-pesqueros de la Lisa Mugil cephalus L. en el litoral peruano

La lisa Mugil cephalus, es uno de los recursos que sustentan la pesquería artesanal en el Perú; a pesar de su importancia, escasos son los estudios relacionados con su biología. Con el objeto de determinar su biología y pesquería, se analizan las cifras de desembarques de las Estadísticas de la Pesquería Marina (Flores et al., 1994) de los años 1980 a 1992, las cifras de captura por artes de pesca obtenidas por la pesca artesanal en once caletas del litoral peruano entre los años 1986 y 1988, y, para el estudio de los aspectos biológicos, la información de los Laboratorios Costeros del IMARPE: Paita (05°05 ' S), Callao (12°03 'S), Pisco (13°44 'S) e Ilo (17°38.4 'S), periodo 1979 a 1992. La lisa se distribuye en toda la costa del Perú con mayores volúmenes de captura en el norte del país (5° a 7° S); en el sur, los valores suelen ser bajos. En Paita los ejemplares capturados se encontraron por encima de la talla mínima reglamentaria de captura (35 cm), mientras que en Callao, Pisco e Ilo, por debajo de la misma. La longitud media a la cual el 50% de individuos alcanza su primera madurez es 29 cm y 34 cm al primer desove. Los valores de índice gonadosomático (IGS), indican que la lisa desova en primavera-verano. El análisis de la relación peso-longitud separada por sexos en las zonas de Paita, Callao, Pisco e Ilo mostró que las hembras alcanzaron mayores pesos que los machos a la misma longitud. En ambos sexos se evidenció un crecimiento isométrico.

Daniel Weinstock interviews Lisa Eckenwiler and Chris Macdonald -- music by General International

Daniel Weinstock, director of CRÉUM, interviews two professors that were invited to pursue their work at CRÉUM during the summer of 2008. His invitees are Lisa Eckenwiler, Associate Professor of Philosophy in the Department of Philosophy and in the Department of Health Administration and Policy at George Mason University; and Chris Macdonald, Associate Professor of Philosophy at Saint Mary’s University in Halifax. You will also hear General International, an experimental/avant-garde music band that was formed only a few months ago.